tiprankstipranks
Oncolytics Biotech (ONCY)
NASDAQ:ONCY
US Market
ONCY
Oncolytics Biotech
RESEARCH TOOLSreports

Oncolytics Biotech (ONCY) Income Statement

1,544 Followers

Oncolytics Biotech Income Statement

Last quarter (Q4 2025), Oncolytics Biotech's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q4, Oncolytics Biotech's net income was C$-1.51M. See Oncolytics Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 0.00C$ 0.00C$ -298.59KC$ -301.11KC$ -360.57K
Operating Expenses
C$ 28.73MC$ 34.98MC$ 24.74MC$ 20.38MC$ 20.56M
Depreciation and Amortization
C$ 70.00KC$ 102.00KC$ 298.59KC$ 301.11KC$ 360.57K
EBITDA
C$ -28.73MC$ -34.88MC$ -20.19MC$ -18.71MC$ -20.58M
Operating Income
C$ -28.73MC$ -34.98MC$ -25.04MC$ -20.68MC$ -20.93M
Other Income/Expenses
C$ 45.00KC$ 3.40MC$ 4.55MC$ 1.67MC$ -15.88K
Pretax Income
C$ -28.68MC$ -31.58MC$ -20.49MC$ -19.01MC$ -20.94M
Net Income
C$ -28.76MC$ -31.71MC$ -20.56MC$ -19.08MC$ -20.98M
Per Share Metrics
Basic EPS
C$ -0.30C$ -0.41C$ -0.41C$ -0.43C$ -0.49
Diluted EPS
C$ -0.30C$ -0.41C$ -0.41C$ -0.43C$ -0.49
Weighted Average Shares Outstanding
 95.86M 76.48M 67.62M 58.03M 53.51M
Weighted Average Shares Outstanding (Diluted)
 95.86M 76.48M 67.62M 58.03M 53.51M
Currency in CAD

Oncolytics Biotech Earnings and Revenue History